We bring the most advanced AI technologies together to connect, combine, and analyze all public pharmaceutical and medical knowledge and data together in Nuron MedPharma. Integration of Nuron MedPharma with companies' internal knowledge enables machine-augmented decision-making in all organizations.
Seamless tech transfer to scale operations with lower cost and risk through developing formulations faster.
Implement Pharma 4.0 to predict outcomes and reduce failure risks.
Increase success and reduce risks for more informed clinical trials with lower costs.
Provide comprehensive medical information for better patient outcomes to save lives.
Better inventions reduce experiments with AI-enabled drug discovery.
Increase product quality eliminate missing information risk with faster regulatory application preparation.
70% reduction in R&D and scale up by connecting global facilities and use of predictive machine learning.
Drug Product Technical report bot created $12 M value and saved 160 man-years.
Saving 90% of manual data analysis work by automation, standardization, and democratization of complex data analysis.
Reduced time for FDA application preparation from 75 days to 7 days. Automation of other internal reports.
Implementation of Pharma 4.0, QbD, ICH, and other good manufacturing and data practices.
80% reduction in failure risks by predicting outcome of experiments and finding similar experiments already done.